These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 6826812

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Reduction of increased polyamine levels in psoriatic lesions by retinoid and PUVA treatments.
    Lauharanta J, Kousa M, Kapyaho K, Linnamaa K, Mustakallio K.
    Br J Dermatol; 1981 Sep; 105(3):267-72. PubMed ID: 7272207
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical, ultrastructural and biochemical effects of an aromatic retinoid (etretinate) on psoriasis and Darier's disease.
    Lauharanta J.
    Acta Derm Venereol Suppl (Stockh); 1982 Sep; 101():1-29. PubMed ID: 6954822
    [No Abstract] [Full Text] [Related]

  • 6. Oral retinoid for psoriasis. A report of a double blind study.
    Pettit JH.
    Acta Derm Venereol Suppl (Stockh); 1979 Sep; 59(85):133-6. PubMed ID: 393035
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders.
    Ward A, Brogden RN, Heel RC, Speight TM, Avery GS.
    Drugs; 1983 Jul; 26(1):9-43. PubMed ID: 6224672
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Methotrexate and etretinate as concurrent therapies in severe psoriasis.
    Vanderveen EE, Ellis CN, Campbell JP, Case PC, Voorhees JJ.
    Arch Dermatol; 1982 Sep; 118(9):660-2. PubMed ID: 7114868
    [Abstract] [Full Text] [Related]

  • 13. [Etretinate: pro and con. Risk-benefit analysis of systemic retinoid therapy in psoriasis and recent developments: free aromatic acid, arotinoids].
    Gollnick H, Orfanos CE.
    Hautarzt; 1985 Jan; 36(1):2-9. PubMed ID: 3156105
    [Abstract] [Full Text] [Related]

  • 14. Systemic treatment of psoriasis with an oral retinoic acid derivative (Ro 10-9359).
    Lassus A.
    Br J Dermatol; 1980 Feb; 102(2):195-202. PubMed ID: 6992833
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association of etretinate and fish oil in psoriasis therapy. Inhibition of hypertriglyceridemia resulting from retinoid therapy after fish oil supplementation.
    Frati C, Bevilacqua L, Apostolico V.
    Acta Derm Venereol Suppl (Stockh); 1994 Feb; 186():151-3. PubMed ID: 8073820
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.